- CNO Ticker
- πΊπΈ NYSE Exchange
- 3,300 Employees
- π° Financials Sector
- π§πΌβπΌ Insurance Industry
- Gary C. Bhojwani CEO
Financial statements β CNO Financial Group
The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 β 16 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|
Total Revenue |
|
3.8B | 4B | 4.3B | 4.3B | 4B |
Cost Of Revenue |
|
0 | 0 | 0 | 0 | 0 |
Gross Profit |
|
3.8B | 4B | 4.3B | 4.3B | 4B |
Research and Development |
|
0 | 0 | 0 | 0 | 0 |
Selling General and Admin |
|
0 | 0 | 0 | 0 | 0 |
Operating Expense |
|
3.5B | 3.7B | 4.6B | 3.8B | 3.6B |
Operating Income |
|
340M | 280M | -260M | 480M | 350M |
Other Income Expense Net |
|
0 | 0 | 0 | 0 | 0 |
EBIT |
|
340M | 280M | -260M | 480M | 350M |
Interest Income |
|
0 | 0 | 0 | 0 | 0 |
Pretax Income |
|
340M | 270M | -260M | 480M | 350M |
Income Tax |
|
43M | -140M | 50M | 300M | -5M |
Minority Interest |
|
0 | 0 | 0 | 0 | 0 |
Net Income |
|
300M | 410M | -320M | 180M | 360M |
Net Income Basic |
|
300M | 410M | -320M | 180M | 360M |
20 β 16 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|
Current cash |
|
0 | 0 | 0 | 0 | 0 |
Short term investments |
|
27B | 24B | 22B | 27B | 25B |
Receivables |
|
4.6B | 4.8B | 4.9B | 2.2B | 2.3B |
Inventory |
|
0 | 0 | 0 | 0 | 0 |
Other current assets |
|
460M | 480M | 550M | 610M | 640M |
Current assets |
|
34B | 32B | 29B | 31B | 30B |
Long term investments |
|
1.7B | 2.1B | 2.3B | 1.7B | 2.2B |
Property plant equipment |
|
0 | 0 | 0 | 0 | 0 |
Goodwill |
|
0 | 0 | 0 | 0 | 0 |
Intangible assets |
|
0 | 0 | 0 | 0 | 0 |
Other assets |
|
1.7B | 2.1B | 2.3B | 1.7B | 2.2B |
Total assets |
|
35B | 34B | 31B | 33B | 32B |
Accounts payable |
|
0 | 0 | 0 | 0 | 0 |
Current long term debt |
|
3.9B | 3.8B | 4B | 4B | 4.2B |
Other current liabilities |
|
25B | 24B | 23B | 24B | 23B |
Total current liabilities |
|
29B | 28B | 27B | 28B | 27B |
Long term debt |
|
0 | 0 | 0 | 0 | 0 |
Other liabilities |
|
820M | 750M | 630M | 750M | 610M |
Minority Interest |
|
0 | 0 | 0 | 0 | 0 |
Total Liabilities |
|
30B | 29B | 28B | 28B | 27B |
Common stock |
|
140M | 160M | 170M | 170M | 180M |
Retained earning |
|
750M | 540M | 200M | 560M | 650M |
Treasury stock |
|
0 | 0 | 0 | 0 | 0 |
Capital surplus |
|
β’ | β’ | β’ | β’ | β’ |
Shareholder equity |
|
5.5B | 4.7B | 3.4B | 4.8B | 4.5B |
Net tangible assets |
|
5.5B | 4.7B | 3.4B | 4.8B | 4.5B |
20 β 16 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|
Net Income |
|
300M | 410M | -320M | 180M | 360M |
Depreciation |
|
300M | 270M | 290M | 270M | 280M |
Changes in receivables |
|
-200M | -140M | 2.8B | -85M | -600M |
Changes in inventories |
|
0 | 0 | 0 | 0 | 0 |
Cash change |
|
340M | -1.9M | -100M | 89M | -130M |
Cash flow |
|
740M | 700M | 320M | 610M | 760M |
Capital expenditures |
|
0 | 0 | 0 | 0 | 0 |
Investments |
|
β’ | β’ | β’ | β’ | β’ |
Investing activity other |
|
β’ | β’ | β’ | β’ | β’ |
Total investing cash flows |
|
-610M | -560M | -530M | -240M | -740M |
Dividends paid |
|
β’ | β’ | β’ | β’ | β’ |
Net borrowings |
|
-24B | -22B | -20B | -24B | -23B |
Other financing cash flows |
|
β’ | β’ | β’ | β’ | β’ |
Cash flow financing |
|
210M | -140M | 110M | -270M | 30M |
Exchange rate effect |
|
β’ | β’ | β’ | β’ | β’ |
Analyst Recommendations
This chart is a recommendation for investors. To provide forecasts, analysts and brokers use companies' public financial reports and speak with their employees and clients. The end result is a solution that's marked on the chart, which shows analysts' opinions at different periods of time. Move your cursor to track on what the dates the recommendations changed.
Investors shouldn't only follow analyst recommendations. Forecasts should be used to supplement existing strategies and plans. Trading based on a recommendation chart is is considered bad practice. Analyst reports should only be used in conjunction with your own analytics.
Also known as strong sell, it's a recommendation to sell a security or to liquidate an asset.
A recommendation that means a stock is expected to do slightly worse than the overall stock market return. Underperform can also be expressed as "moderate sell", "weak hold" and "underweight."
A company with a hold recommendation is expected to perform on par with comparable companies or in line with the market.
Also known as "moderate buy", "accumulate", and "overweight." Outperform is an analyst recommendation meaning a stock is expected to do slightly better than the market return.
Also known as strong buy and "on the recommended list." Needless to say, buy is a recommendation to purchase a specific security.
Also known as strong sell, it's a recommendation to sell a security or to liquidate an asset.
A recommendation that means a stock is expected to do slightly worse than the overall stock market return. Underperform can also be expressed as "moderate sell", "weak hold" and "underweight."
A company with a hold recommendation is expected to perform on par with comparable companies or in line with the market.
Also known as "moderate buy", "accumulate", and "overweight." Outperform is an analyst recommendation meaning a stock is expected to do slightly better than the market return.
Also known as strong buy and "on the recommended list." Needless to say, buy is a recommendation to purchase a specific security.
CNO Financial Group, Inc. is an insurance holding company, which develops, markets and administers health insurance, annuity, individual life insurance and other insurance products. It operates through the following segments: Bankers Life, Washington National, Colonial Penn. The Bankers Life segment markets and distributes medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents and sales managers supported by a network of community-based sales offices. The Washington National segment markets and distributes supplemental health including specified disease, accident and hospital indemnity insurance products and life insurance to middle-income consumers at home and at the worksite. The Colonial Penn segment markets primarily graded benefit and simplified issue life insurance directly to customers in the senior middle-income market through television advertising, direct mail, the internet and telemarketing. The company was founded in 1979 and is headquartered in Carmel, IN.